Protect Yourself and Your Patients From Fraud in Genetic Testing
Genetic testing has come a long way in cancer care, but not all genetic tests are as defentive as some would have you or your patients beleive.
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
